Blood Testing Market Analysis By Test Type, (Glucose, Lipid panel, Direct LDL, Prostate Specific Antigen, BUN, A1C, High Sensitivity CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone, Creatinine, Serum Nicotine/Cotinine, Cortisol, Testosterone) And Segment Forecasts To 2024

Published: Mar, 2013 | Pages: 91 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

Global blood testing market is anticipated to reach USD 62.9 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of testing and screening methodologies that enhance near patient diagnosis through enhanced blood testing that reduce diagnostic turnaround times and lower hospitals stay durations is a major factor expected to provide lucrative growth in demand for the market.

Federal agencies that play a major role in regulation of genetic tests, including Centers for Medicare and Medicaid Services, Food and Drug Administration, and Federal Trade Commission, have also undertaken initiatives expected to further enhance market usage of Clinical Laboratory Improvement Amendments (CLIA) compliant tests in the market. These steps reinforce the goals set by national governments and the medical fraternities to strengthen early diagnostic capabilities across a number of key geographic regions.

Increasing levels of patient awareness that have been witnessed in a number of demographic factions across developed and developing countries alike is another notable factor expected to drive growth. Growing prevalence of chronic diseases such as diabetes that warrant long term disease managementis also a considerable factor attributive of growth potential over the forecast period.

Further key findings from the study suggest:

Glucose testing is estimated to be the dominant segment in 2015 owing to the high number of awareness programs carried out by various diabetes management focused associations. Presence of several local and established players in this segment that serve the market with a broad portfolio of point-of-care and portable meters for blood glucose monitoring is another factor reinforcing the dominance of this segment.

Market revenue from of lipid panel tests is second only to blood glucose monitoring and their strong market position can be accounted for by higher incidence of cholesterol associated cardiovascular disorders as a consequence of sedentary lifestyle, need for risk analysis of cardiac diseases and screening for probability of congestive heart failure.

Glycated hemoglobin (aka A1C) is anticipated to witness relatively faster growth among the market segments over the forecast period owing to associated higher patient convenience, faster turnaround time, higher accuracy and reliability for testing.

North America dominated the industry in 2015, with over 40% of total revenue. Technological advancements such as the introduction of miniaturized diagnostic devices rendering rapid and accurate results that have higher market penetration in the region coupled with favorable medical insurance policies enhancing market adoption are attributive for the largest share. Favorable government initiatives and CLIA waiver on POC testing devices are also notable factors estimated drive growth.

Asia Pacific is estimated to witnessthe fastest growth over the forecast period owing to presence of high unmet medical needs pertaining to target disease segments such as cardiovascular disorders, prostate cancer, diabetes, liver diseases, hepatotoxicity, and hyperlipedemia.

Moreover, constantly improving healthcare expenditure in developing economies and ongoing initiatives taken by key market participants to strengthen their presence in these untapped pockets of the market is expected to drive regional market development through to 2024.

Key players operating in this industry includeRoche Diagnostics, Abbott diagnostics, Bio-Rad Laboratories, Becton Dickinson & Company, Alere, Trinity Biotech PLC, BioMerieux SA, Nipro Diagnostics, Biomerica Inc, Siemens Healthcare, and Beckman Coulter.

Introduction of the combination plans and other promotion programs by the clinics and laboratories which provide complete analysis of the blood are factors attributive for the projected growth in the coming years

These entities are adopting strategies such as collaborations with hospitalsand diagnostic laboratories in order to provide online testing services. Such services include ordering a test online, carrying out the test and submission to the authorized laboratory, and retrieval of the results via e-mail so as to reduce the number of hospital visits.

 Table of Contents

Chapter 1 Methodology and Scope
                    1.1 Research Methodology
                    1.2 Research Scope & Assumptions
                    1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Blood Testing Industry Outlook
                    3.1 Market segmentation
                    3.2 Market size and growth prospects, 2013 - 2024
                    3.3 Blood testing market dynamics
                         3.3.1 Market driver analysis
                                3.3.1.1 Growing prevalence of target diseases
                                3.3.1.2 Growing demand for home healthcare and the introduction of advance technology enabled products
                                3.3.1.3 Implementation of favorable government initiatives & external funding for R&D exercises
                                3.3.1.4 Introduction of CLIA waived tests
                                3.3.1.5 Rising demand for early disease detection
                         3.3.2 Market Restraint Analysis
                                3.3.2.1 High procedure costs
                    3.4 Key Opportunities Prioritized
                         3.4.1 Key Opportunities Prioritized - Segments Forecast Over USD 1.5 Billion by 2024
                         3.4.2 Key Opportunities Prioritized - Segments Forecast Up-to 1.5 Billion by 2024
                    3.5 Industry analysis - Porter's
                    3.6 Blood testing PESTEL Analysis
Chapter 4 Blood Testing Type Outlook
                    4.1 Global blood testing revenue share, by type, 2015 & 2024
                    4.2 Glucose testing
                         4.2.1 Glucose testing market, 2013 - 2024 (USD Million)
                    4.3 Lipid panel testing
                         4.3.1 Lipid panel testing market, 2013 - 2024 (USD Million)
                    4.4 Direct LDL testing
                         4.4.1 Direct LDL testing market, 2013 - 2024 (USD Million)
                    4.5 Prostate Specific Antigen (PSA) testing
                         4.5.1 Prostate specific antigen testing market, 2013 - 2024 (USD Million)
                    4.6 Blood Urea Nitrogen (BUN) testing
                         4.6.1 Blood Urea Nitrogen (BUN) testing market, 2013 - 2024 (USD Million)
                    4.7 A1C testing
                         4.7.1 A1C testing market, 2013 - 2024 (USD Million)
                    4.8 High Sensitivity C-Reactive Protein (hs-CRP) testing
                         4.8.1 High sensitivity CRP testing market, 2013 - 2024 (USD Million)
                    4.9 Vitamin D testing
                         4.9.1 Vitamin D testing market, 2013 - 2024 (USD Million)
                    4.10 ALT testing
                         4.10.1 ALT testing market, 2013 - 2024 (USD Million)
                    4.11 Thyroid stimulating hormone testing
                         4.11.1 Thyroid stimulating hormone testing market, 2013 - 2024 (USD Million)
                    4.12 Creatinine testing
                         4.12.1 Creatinine testing market, 2013 - 2024 (USD Million)
                    4.13 Serum nicotine / cotinine testing
                         4.13.1 Serum nicotine/cotinine testing market, 2013 - 2024 (USD Million)
                    4.14 AST testing
                         4.14.1 AST testing market, 2013 - 2024 (USD Million)
                    4.15 Cortisol testing
                         4.15.1 Cortisol testing market, 2013 - 2024 (USD Million)
                    4.16 Testosterone testing
                         4.16.1 Testosterone testing market, 2013 - 2024 (USD Million)
Chapter 5 Blood Testing Regional Outlook
                    5.1 Blood Testing Revenue Share by Region, 2015 & 2024
                    5.2 North America
                         5.2.1 North America blood testing market, 2013 - 2024 (USD Million)
                         5.2.2 U.S.
                                5.2.2.1 U.S. blood testing market, 2013 - 2024 (USD Million)
                    5.3 Europe
                         5.3.1 Europe blood testing market, 2013 - 2024 (USD Million)
                         5.3.2 Germany
                                5.3.2.1 Germany blood testing market, 2013 - 2024 (USD Million)
                         5.3.3 UK
                                5.3.3.1 UK blood testing market, 2013 - 2024 (USD Million)
                         5.3.4 Russia
                                5.3.4.1 Russia blood testing market, 2013 - 2024 (USD Million)
                         5.3.5 Turkey
                                5.3.5.1 Turkey blood testing market, 2013 - 2024 (USD Million)
                    5.4 Asia Pacific
                         5.4.1 Asia Pacific blood testing market, 2013 - 2024 (USD Million)
                         5.4.2 China
                                5.4.2.1 China blood testing market, 2013 - 2024 (USD Million)
                         5.4.3 India
                                5.4.3.1 India blood testing market, 2013 - 2024 (USD Million)
                         5.4.4 Indonesia
                                5.4.4.1 Indonesia blood testing market, 2013 - 2024 (USD Million)
                    5.5 Latin America
                         5.5.1 Latin America blood testing market, 2013 - 2024 (USD Million)
                         5.5.2 Brazil
                                5.5.2.1 Brazil blood testing market, 2013 - 2024 (USD Million)
                         5.5.3 Mexico
                                5.5.3.1 Mexico blood testing market, 2013 - 2024 (USD Million)
                    5.6 MEA
                         5.6.1 MEA blood testing market, 2013 - 2024 (USD Million)
                         5.6.2 South Africa
                                5.6.2.1 South Africa blood testing market, 2013 - 2024 (USD Million)
                         5.6.3 Nigeria
                                5.6.3.1 Nigeria blood testing market, 2013 - 2024 (USD Million)
Chapter 6 Competitive Landscape
                    6.1 Abbott Diagnostics
                         6.1.1 Company Overview
                         6.1.2 Financial Performance
                         6.1.3 Product Benchmarking
                         6.1.4 Strategic Initiatives
                    6.2 Bio-Rad Laboratories Inc.
                         6.2.1 Company Overview
                         6.2.2 Financial Performance
                         6.2.3 Product Benchmarking
                         6.2.4 Strategic Initiatives
                    6.3 Roche Diagnostics
                         6.3.1 Company Overview
                         6.3.2 Financial Performance
                         6.3.3 Product benchmarking
                         6.3.4 Strategic initiatives
                    6.4 Quest Diagnostics
                         6.4.1 Company overview
                         6.4.2 Financial Performance
                         6.4.3 Product benchmarking
                         6.4.4 Strategic initiatives
                    6.5 Danaher Corporation (Beckman Coulter Inc. and Radiometer)
                         6.5.1 Company Overview
                         6.5.2 Financial Performance
                         6.5.3 Product benchmarking
                         6.5.4 Strategic initiatives
                    6.6 Becton Dickinson & Company
                         6.6.1 Company Overview
                         6.6.2 Financial Performance
                         6.6.3 Product Benchmarking
                         6.6.4 Strategic Initiatives
                    6.7 Biomerica, Inc
                         6.7.1 Company Overview
                         6.7.2 Financial Performance
                         6.7.3 Product Benchmarking
                         6.7.4 Strategic Initiatives
                    6.8 BioMerieux S.A.
                         6.8.1 Company Overview
                         6.8.2 Financial Performance
                         6.8.3 Product Benchmarking
                         6.8.4 Strategic Initiatives
                    6.9 Siemens Healthcare
                         6.9.1 Company Overview
                         6.9.2 Financial Performance
                         6.9.3 Product Benchmarking
                         6.9.4 Strategic Initiatives
                    6.10 Trinity Biotech PLC
                         6.10.1 Company Overview
                         6.10.2 Financial Performance
                         6.10.3 Product Benchmarking
                         6.10.4 Strategic Initiatives
                    6.11 Alere Inc
                         6.11.1 Company Overview
                         6.11.2 Financial Performance
                         6.11.3 Product Benchmarking
                         6.11.4 Strategic Initiatives
                    6.12 Nipro Diagnostics/Trividia Healthcare
                         6.12.1 Company Overview
                         6.12.2 Financial Performance
                         6.12.3 Product Benchmarking
                         6.12.4 Strategic Initiatives

List of Tables

TABLE 1 Blood Testing - Industry Snapshot & Key Buying Criteria, 2013 - 2024
TABLE 2 Global blood testing market estimates, by type, 2013 - 2015 (USD Million)
TABLE 3 Global blood testing market forecasts, by type, 2016 - 2024 (USD Million)
TABLE 4 Blood testing market estimates, by region, 2013 - 2015 (USD Million)
TABLE 5 Blood testing market, by region, 2016 - 2024 (USD Million)
TABLE 6 Blood testing key market driver analysis
TABLE 7 Blood testing - Key market restraint analysis
TABLE 8 North America blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 9 North America glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 10 North America lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 11 North America direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 12 North America PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 13 North America BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 14 North America A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 15 North America high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 16 North America vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 17 North America ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 18 North America thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 19 North America creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 20 North America serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 21 North America AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 22 North America cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 23 North America testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 24 North America other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 25 U.S. blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 26 U.S. glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 27 U.S. lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 28 U.S. direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 29 U.S. PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 30 U.S. BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 31 U.S. A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 32 U.S. high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 33 U.S. vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 34 U.S. ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 35 U.S. thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 36 U.S. creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 37 U.S. serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 38 U.S. AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 39 U.S. cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 40 U.S. testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 41 U.S. other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 42 Europe blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 43 Europe glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 44 Europe lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 45 Europe direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 46 Europe PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 47 Europe BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 48 Europe A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 49 Europe high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 50 Europe vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 51 Europe ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 52 Europe thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 53 Europe creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 54 Europe serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 55 Europe AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 56 Europe cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 57 Europe testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 58 Europe other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 59 Germany blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 60 Germany glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 61 Germany lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 62 Germany direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 63 Germany PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 64 Germany BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 65 Germany A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 66 Germany high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 67 Germany vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 68 Germany ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 69 Germany thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 70 Germany creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 71 Germany serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 72 Germany AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 73 Germany cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 74 Germany testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 75 Germany other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 76 UK blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 77 UK glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 78 UK lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 79 UK direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 80 UK PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 81 UK BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 82 UK A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 83 UK high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 84 UK vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 85 UK ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 86 UK thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 87 UK creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 88 UK serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 89 UK AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 90 UK cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 91 UK testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 92 UK other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 93 Russia blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 94 Russia glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 95 Russia lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 96 Russia direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 97 Russia PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 98 Russia BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 99 Russia A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 100 Russia high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 101 Russia vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 102 Russia ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 103 Russia thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 104 Russia creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 105 Russia serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 106 Russia AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 107 Russia cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 108 Russia testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 109 Russia other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 110 Turkey blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 111 Turkey glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 112 Turkey lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 113 Turkey direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 114 Turkey PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 115 Turkey BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 116 Turkey A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 117 Turkey high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 118 Turkey vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 119 Turkey ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 120 Turkey thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 121 Turkey creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 122 Turkey serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 123 Turkey AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 124 Turkey cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 125 Turkey testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 126 Turkey other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 127 Asia Pacific blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 128 Asia Pacific glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 129 Asia Pacific lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 130 Asia Pacific direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 131 Asia Pacific PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 132 Asia Pacific BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 133 Asia Pacific A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 134 Asia Pacific high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 135 Asia Pacific vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 136 Asia Pacific ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 137 Asia Pacific thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 138 Asia Pacific creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 139 Asia Pacific serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 140 Asia Pacific AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 141 Asia Pacific cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 142 Asia Pacific testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 143 Asia Pacific other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 144 China blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 145 China glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 146 China lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 147 China direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 148 China PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 149 China BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 150 China A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 151 China high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 152 China vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 153 China ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 154 China thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 155 China creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 156 China serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 157 China AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 158 China cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 159 China testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 160 China other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 161 India blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 162 India glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 163 India lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 164 India direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 165 India PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 166 India BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 167 India A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 168 India high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 169 India vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 170 India ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 171 India thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 172 India creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 173 India serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 174 India AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 175 India cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 176 India testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 177 India other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 178 Indonesia blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 179 Indonesia glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 180 Indonesia lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 181 Indonesia direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 182 Indonesia PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 183 Indonesia BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 184 Indonesia A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 185 Indonesia high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 186 Indonesia vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 187 Indonesia ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 188 Indonesia thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 189 Indonesia creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 190 Indonesia serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 191 Indonesia AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 192 Indonesia cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 193 Indonesia testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 194 Indonesia other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 195 Latin America blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 196 Latin America glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 197 Latin America lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 198 Latin America direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 199 Latin America PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 200 Latin America BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 201 Latin America A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 202 Latin America high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 203 Latin America vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 204 Latin America ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 205 Latin America thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 206 Latin America creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 207 Latin America serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 208 Latin America AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 209 Latin America cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 210 Latin America testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 211 Latin America other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 212 Brazil blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 213 Brazil glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 214 Brazil lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 215 Brazil direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 216 Brazil PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 217 Brazil BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 218 Brazil A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 219 Brazil high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 220 Brazil vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 221 Brazil ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 222 Brazil thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 223 Brazil creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 224 Brazil serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 225 Brazil AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 226 Brazil cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 227 Brazil testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 228 Brazil other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 229 Mexico blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 230 Mexico glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 231 Mexico lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 232 Mexico direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 233 Mexico PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 234 Mexico BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 235 Mexico A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 236 Mexico high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 237 Mexico vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 238 Mexico ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 239 Mexico thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 240 Mexico creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 241 Mexico serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 242 Mexico AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 243 Mexico cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 244 Mexico testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 245 Mexico other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 246 MEA blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 247 MEA glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 248 MEA lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 249 MEA direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 250 MEA PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 251 MEA BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 252 MEA A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 253 MEA high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 254 MEA vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 255 MEA ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 256 MEA thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 257 MEA creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 258 MEA serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 259 MEA AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 260 MEA cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 261 MEA testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 262 MEA other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 263 South Africa blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 264 South Africa glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 265 South Africa lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 266 South Africa direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 267 South Africa PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 268 South Africa BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 269 South Africa A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 270 South Africa high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 271 South Africa vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 272 South Africa ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 273 South Africa thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 274 South Africa creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 275 South Africa serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 276 South Africa AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 277 South Africa cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 278 South Africa testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 279 South Africa other blood tests market, by test location, 2013 - 2024 (USD Million)
TABLE 280 Nigeria blood testing market, by type, 2013 - 2024 (USD Million)
TABLE 281 Nigeria glucose testing market, by test location, 2013 - 2024 (USD Million)
TABLE 282 Nigeria lipid panel testing market, by test location, 2013 - 2024 (USD Million)
TABLE 283 Nigeria direct LDL testing market, by test location, 2013 - 2024 (USD Million)
TABLE 284 Nigeria PSA testing market, by test location, 2013 - 2024 (USD Million)
TABLE 285 Nigeria BUN testing market, by test location, 2013 - 2024 (USD Million)
TABLE 286 Nigeria A1C testing market, by test location, 2013 - 2024 (USD Million)
TABLE 287 Nigeria high sensitivity CRP testing market, by test location, 2013 - 2024 (USD Million)
TABLE 288 Nigeria vitamin D testing market, by test location, 2013 - 2024 (USD Million)
TABLE 289 Nigeria ALT testing market, by test location, 2013 - 2024 (USD Million)
TABLE 290 Nigeria thyroid stimulating hormone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 291 Nigeria creatinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 292 Nigeria serum nicotine/cotinine testing market, by test location, 2013 - 2024 (USD Million)
TABLE 293 Nigeria AST testing market, by test location, 2013 - 2024 (USD Million)
TABLE 294 Nigeria cortisol testing market, by test location, 2013 - 2024 (USD Million)
TABLE 295 Nigeria testosterone testing market, by test location, 2013 - 2024 (USD Million)
TABLE 296 Nigeria other blood tests market, by test location, 2013 - 2024 (USD Million)